CI · Cigna Corporation

The Cigna Group delivered a strong first quarter 2026, with total revenues increasing 5% to $68.5 billion, primarily driven by growth in Evernorth Health Services. Adjusted income from operations rose 12% to $2.1 billion, or $7.79 per share, surpassing the prior year's $6.74 per share. This performance reflects disciplined execution and deliberate portfolio shaping, according to Chairman and CEO David M. Cordani. The Evernorth Health Services segment saw adjusted revenues increase 9% year-over-year to $58.4 billion, with Specialty and Care Services contributing significantly through strong organic growth and increased generic and biosimilar adoption. However, Pharmacy Benefit Services experienced a 28% decrease in pre-tax adjusted income due to expected lower contributions from large client relationships. The Cigna Healthcare segment demonstrated robust improvement, with adjusted income from operations pre-tax increasing 18% to $1.5 billion, driven by improved margins in U.S. Healthcare and International Health. The segment's medical care ratio improved to 79.8% from 82.2% in the prior year. Reflecting confidence in its performance, the company raised its full-year 2026 outlook for adjusted income from operations to at least $30.35 per share, a $0.10 increase from prior projections. The debt-to-capitalization ratio improved slightly to 42.3% from 43.0% at the end of 2025.